Symbiotec Pharmalab Ltd Quarterly Result
Symbiotec Pharmalab Ltd
NSE: SYMBIOTEC
Net Profit - Last Quarter
null Quarterly Results Key Highlights
- The revenue of Symbiotec Pharmalab Ltd for the Jun '26 is ₹ 218.49 crore as compare to the Mar '26 revenue of ₹ 245.41 crore.
- This represent the decline of -10.97% The ebitda of Symbiotec Pharmalab Ltd for the Jun '26 is ₹ 45.54 crore as compare to the Mar '26 ebitda of ₹ 62.25 crore.
- This represent the decline of -26.84% The net profit of Symbiotec Pharmalab Ltd for the Jun '26 is ₹ 14.06 crore as compare to the Mar '26 net profit of ₹ 27.53 crore.
- This represent the decline of -48.93%.
null Quarterly Results Analysis
Market Price of Symbiotec Pharmalab Ltd
1M
1Y
3Y
5Y
Last Ten Days Market Price
| Date |  Price (₹) |
|---|---|
| 30 Sep 2026 | 1176.05 |
| 29 Sep 2026 | 1144.35 |
| 28 Sep 2026 | 1056.75 |
| 25 Sep 2026 | 1002.55 |
| 24 Sep 2026 | 1024.95 |
| 23 Sep 2026 | 1062.15 |
| 22 Sep 2026 | 1121.25 |
| 21 Sep 2026 | 1158.45 |
| 18 Sep 2026 | 1093.25 |
| 17 Sep 2026 | 1046.8 |
Historical Revenue of Symbiotec Pharmalab Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services. Types of Revenue: 1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered. 2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees. Formula for Revenue: The formula for calculating revenue is based on two goods & services: For goods: Revenue = Avg unit price x Number of Units sold For services: Revenue = Avg unit price x Number of Customers served.
Historical Revenue of Symbiotec Pharmalab Ltd
Historical EBITDA of Symbiotec Pharmalab Ltd
PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.
Historical EBITDA of Symbiotec Pharmalab Ltd
Historical Net Profit of Symbiotec Pharmalab Ltd
Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions. Net Profit formula is expressed as: Net Profit = Total Revenue - Total Expense Net Profit Margin Ratio: Net Profit Margin Ratio = Net Profit / Total Revenue
Historical Net Profit of Symbiotec Pharmalab Ltd
Symbiotec Pharmalab Ltd News Hub
Symbiotec Pharmalab to announce Quarterly Result
Symbiotec Pharmalab will hold a meeting of the Board of Directors of the Company on 21 September 202
Read more
12 Sept 26
Symbiotec Pharmalab posts nearly 53% YoY fall in Q1 PAT
Reported EBIDTA declined by 22.1% year-on-year (YoY) to Rs 45.2 crore while reported EBIDTA margin c
Read more
22 Sept 26
Symbiotec Pharmalab IPO ends with 71.26 times subcription
The initial public offer of Symbiotec Pharmalab received bids for 93,52,49,700 shares as against 1,3
Read more
28 Aug 26
Symbiotec Pharmalab consolidated net profit declines 53.01% in the June 2026 quarter
Net profit of Symbiotec Pharmalab declined 53.01% to Rs 14.06 crore in the quarter ended June 2026 a
Read more
23 Sept 26
Document
Annual Reports
N/A
Credit Ratings
N/A
Concalls
Data not available
Data not available
Popular Search
About Symbiotec Pharmalab Ltd
- Symbiotec Pharmalab Private Limited was incorporated as a private limited company, dated September 20, 2002, with the Registrar of Companies, Madhya Pradesh and Chhattisgarh.
- Subsequently, the name of the Company was changed to Symbiotec Pharmalab Limited and a fresh certificate of incorporation dated September 26, 2025, was issued by the Central Processing Centre. Symbiotec is one of the few companies globally and only Indian manufacturer having continuous manufacturing for progesterone API manufacturing.
- The Company has its flow chemistry capability being utilized for progesterone in a new block in Pithampur facility.
- It is presently engaged in manufacturing and selling of Active Pharmaceuticals Ingredients (API) and Intermediates. The Company has a global leadership position in corticosteroid and steroidal-hormone active pharmaceutical ingredients.
FAQs for Quarterly Results of null
What key financial metrics are included in Symbiotec Pharmalab Ltd's quarterly results?
When does Symbiotec Pharmalab Ltd announce its quarterly results?
How does Symbiotec Pharmalab Ltd's quarterly performance impact its stock price?
What is the impact of Symbiotec Pharmalab Ltd's quarterly results on dividends?
Are there any special announcements usually made during Symbiotec Pharmalab Ltd's quarterly results?
